News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,839 Results
Type
Article (87425)
Company Profile (760)
Press Release (772632)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233052)
Career Advice (4139)
Deals (39795)
Drug Delivery (136)
Drug Development (91247)
Employer Resources (203)
FDA (18282)
Job Trends (17399)
News (397384)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (125)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (243)
Approvals (18304)
Artificial intelligence (487)
Autoimmune disease (73)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (159)
Biotechnology (484)
Bladder cancer (132)
Brain cancer (52)
Breast cancer (501)
Cancer (3943)
Cardiovascular disease (339)
Career advice (3556)
Career pathing (38)
CAR-T (246)
CDC (57)
Cell therapy (682)
Cervical cancer (33)
Clinical research (75492)
Collaboration (1381)
Company closure (4)
Compensation (938)
Complete response letters (59)
COVID-19 (2956)
CRISPR (81)
C-suite (587)
Cystic fibrosis (135)
Data (4446)
Decentralized trials (2)
Denatured (61)
Depression (110)
Diabetes (452)
Diagnostics (7091)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (230)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (98792)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132968)
Executive appointments (988)
FDA (20737)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1251)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1020)
Government (5384)
Grass and pollen (7)
Guidances (341)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (62)
Immunology and inflammation (241)
Immuno-oncology (20)
Indications (53)
Infectious disease (3193)
Inflammatory bowel disease (187)
Inflation Reduction Act (15)
Influenza (97)
Intellectual property (187)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (16)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (567)
Lymphoma (265)
Machine learning (30)
Management (66)
Manufacturing (635)
MASH (138)
Medical device (14869)
Medtech (14892)
Mergers & acquisitions (22744)
Metabolic disorders (1152)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2711)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (557)
Opinion (312)
Ovarian cancer (133)
Pain (165)
Pancreatic cancer (171)
Parkinson's disease (242)
Partnered (30)
Patents (416)
Patient recruitment (310)
Peanut (57)
People (66252)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23282)
Phase II (32767)
Phase III (24689)
Pipeline (2714)
Policy (295)
Postmarket research (3554)
Preclinical (10496)
Press Release (72)
Prostate cancer (200)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (671)
Real estate (7421)
Recruiting (78)
Regulatory (28002)
Reports (65)
Research institute (2689)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (70)
Schizophrenia (135)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1044)
Venture capital (66)
Weight loss (396)
Women's health (58)
Worklife (21)
Date
Today (164)
Last 7 days (656)
Last 30 days (2430)
Last 365 days (33517)
2025 (26375)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50972)
Australia (8956)
California (9426)
Canada (2855)
China (899)
Colorado (400)
Connecticut (422)
Delaware (270)
Europe (117104)
Florida (1390)
Georgia (315)
Hawaii (3)
Idaho (67)
Illinois (811)
India (51)
Indiana (460)
Iowa (19)
Japan (323)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1275)
Massachusetts (7107)
Michigan (313)
Minnesota (563)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (107)
New Hampshire (77)
New Jersey (2620)
New Mexico (32)
New York (2572)
North Carolina (1410)
North Dakota (10)
Northern California (4259)
Ohio (295)
Oklahoma (22)
Oregon (50)
Pennsylvania (1963)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3602)
Tennessee (149)
Texas (1476)
United States (34898)
Utah (282)
Virginia (248)
Washington D.C. (83)
Washington State (817)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
There are 860,839 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Novo Secures Cardiovascular Expansion for Semaglutide Pill
Rybelsus can now be used as a primary or secondary prevention pill to lower the risk of major adverse cardiovascular events in at-risk patients with type 2 diabetes.
October 20, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Glaukos Notches FDA Nod for Rare Eye Disorder Keratoconus
Glaukos’ Epioxa allows cross-linking therapy for keratoconus without requiring an incision. The biotech expects to launch the drug early next year.
October 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
SunRock Biopharma and Chime Biologics Announce Strategic Collaboration to Advance Development of Anti-CCR9 Antibody SRB5
October 20, 2025
·
3 min read
Press Releases
The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC
October 20, 2025
·
8 min read
Press Releases
Roche’s Tecentriq showed significant overall and disease-free survival benefits in bladder cancer with ctDNA-guided treatment
October 20, 2025
·
7 min read
Press Releases
FDA approves Roche’s Gazyva/Gazyvaro for the treatment of lupus nephritis
October 20, 2025
·
9 min read
Press Releases
Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
October 20, 2025
·
8 min read
Press Releases
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
October 20, 2025
·
12 min read
Press Releases
Updated BEXMAB Phase I/II Data Presented at ESMO 2025 Shows Further Improvement, Strengthening the Clinical Profile of Bexmarilimab in Treatment-Naïve HR-MDS Patients
October 20, 2025
·
9 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
1 of 86,084
Next
